Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Hackers target big brands like McDonald's, Bayer, CarMax in new phishing scam
Op-ed: High Plains Farmers Were Protecting Soil Long Before Corporations Figured Out How to Market It
Leverkusen hold further talks to extend Maza deal as club set sale timeframe
Imaging for localizing and therapeutic management of primary aldosteronism: the primary aldosteronism imaging outcome consensus
What HLS Therapeutics (HLS) Said on Its Q3 Earnings Call - Daily Political
Leverkusen Intensify Pursuit Of Wael Mohya As Bayern Face Competition
I2Pure Scientists Identify a Reliability Gap in Iodine Antiseptics
A New Pill Could Reduce the Risk of Having a Second Stroke
HLS Therapeutics Announces Q3 2026 Financial Results
A roadmap for therapeutic innovation in paediatric chronic kidney disease
South-east Asia's push to keep seniors working faces work-health mismatch - The Business Times
Making Longer Lives Healthier: Bayer Champions Earlier Action on Chronic Disease Across Asia Pacific
Normalized membrane ratio of TROP2 as a predictor of clinical outcomes with datopotamab deruxtecan in non-small-cell lung cancer
Transfer insider outlines Liverpool's stance on selling Frimpong amid reported Saudi interest
Bayer Secures FDA Nod For SUNHARBO In Secondary Stroke Prevention
Bayer's SUNHARBO® (asundexian), 50 mg tablets, the First and Only Factor XIa Inhibitor, Approved by the U.S. FDA to Reduce the Risk of Stroke in Adults With Recent Non-Cardioembolic Ischemic Stroke or High-Risk Transient Ischemic Attack... | Morningstar
FDA clears Bayer's Sunharbo as first factor XIa agent for stroke | BioWorld
US FDA approves Bayer's blood thinner to prevent repeat strokes
Leaked Photo: Susie Wiles Accused Of Banning MAHA Activists From White House
Daybreak Nov. 9: Permitting reform vote slated
Transcript: Calley Means on "Face the Nation with Margaret Brennan," Nov. 8, 2026 - CBS News
Ex-MAHA Insider Tells Rogan What Trump Didn't Know About His Own White House
Millennials Are Paying A Recovery Tax On Their Jobs. Spas See It First
First U.S. Convintro™ Herbicide Delivery Launches a New Weed-Control Option for Corn and Soybean Growers | Morningstar
Global Hemophilia B Gene Therapy Market Report 2026 | Capitalize on 29.8% CAGR as Pfizer, CSL Behring, Bayer, and REGENXBIO Accelerate AAV Innovation
Bayer Consumer Health Deepens China Partnerships to Expand Access
Bayer to invest ₹200 crore in Karnataka; MoU signed
Bayer to Invest ₹200 Cr in Karnataka for New Manufacturing Plant
German Stocks Tumble; DAX Down 1.73%
Korea's IVI supports Minapharm for development of Bundibugyo ebolavirus vaccine
Bayer (XTRA:BAYN) Stock May Still Offer Value Despite NUBEQA Trial News
European firms look to deepen ties with China
Racing Bulls boss fires warning to Liam Lawson over F1 future
What Is Bayer (XTRA:BAYN) Telling Investors With Its Higher 2026 Profit Forecast?
Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Reaches New 12-Month High - Should You Buy? - Stock Observer
Bayer and America's Grow-a-Row Continue Partnership to Fight Food Insecurity | Morningstar
Crop protection rules could widen Europe's farming gap
Bayer Boosts 2026 Profit Forecast Amid Strong Pharma Performance, ETPharma
Bayer Earnings: Outstanding Pharma Growth and Margin; Full-Year Guidance Raised | Morningstar
Karnataka Investment: Astrobase and Bayer pledge Rs 700 cr for new projects
Bayer's Comeback Is Starting to Look Like More Than a Lawsuit Story
Space tech Astrobase to invest ₹500 crore in Karnataka rocket engine facility
Astrobase, Bayer to invest Rs 700 crore in Karnataka, creating nearly 1,500 jobs
What Bayer Aktiengesellschaft (BAYN) Said on Its Q3 Earnings Call
North American Morning Briefing: Stock Futures Mixed As Americans Head to the Polls | Morningstar
European Midday Briefing: Stocks Fall on Investor Caution Ahead of Midterms | Morningstar
Bayer Shares Jump After Pharma Recovery Prompts Outlook Raise | Morningstar
Bayer's third-quarter loss narrows as it raises 2026 guidance
Bayer raises 2026 profit outlook on strong pharmaceuticals performance
Peter Bayer Backs Liam Lawson's 2026 Results Amid Rumors About His Racing Bulls Future - Yahoo Sports
Bayer Posts Narrower Loss In Q3; Improves Full-year Outlook
Bayer Q3 sales, EBITDA beat estimates; raises 2026 earnings and cash flow outlook
PREVIEW | Galatasaray vs Stuttgart: team news, lineups, predictions (Champions League 03/11)
Bayer (XTRA:BAYN) Reaches First Milestone Payment In Crop Biocontrol Partnership
Bayer (XTRA:BAYN) Stock Stays Undervalued On Fresh NUBEQA Trial News
Bone fractures and prior abiraterone use in men treated with radium-223 plus enzalutamide for castration-resistant prostate cancer with bone metastases: a real-world study
Is Bayer (XTRA:BAYN) Undervalued Following Its Roundup Court Win?
What Bayer (XTRA:BAYN)'s Roundup Court Win Means For Shareholders
Next-Generation Adeno-Associated Virus (AAV) Gene Therapy Delivery Market Report 2026 | Capitalize on $11.91B Market as Novartis, Voyager and Affinia Accelerate Engineered Capsids
Global Molecular Breeding Market Opportunities and Strategies to 2035 | Capitalize on Genomic Selection as Bayer, Syngenta, Corteva and BASF Drive a $21.55 Billion Market
Bayer wins Roundup weedkiller cancer trial while awaiting settlement ruling | live
Bayer wins Roundup cancer trial amid settlement ruling | The Straits Times
Bayer Shares Rise After Win in First Roundup Trial Since Supreme Court Ruling
Bayer's Monsanto Wins First Roundup Trial Since Supreme Court's Durnell Ruling, Shares Up
Bayer Wins First U.S. Trial Over Roundup Since Supreme Court Ruling | Morningstar
Monsanto unanimously wins first Roundup™ trial since U.S. Supreme Court decision | Morningstar
Bayer Wins St. Louis Roundup Trial, Bolstering Settlement Push
Bayer wins US trial in which it was alleged that Roundup caused cancer in three women
What BridgeBio Pharma (BBIO) Said on Its Q3 Earnings Call
Glioma Market Size in the 7MM is projected to grow at a significant CAGR of ~15% over the forecast period of 2026-2036 | DelveInsight | ABNewswire
MustGrow and Bayer advance mustard-based biocontrol in Europe, the Middle East, and Africa
Shweta Rai of Bayer Pharmaceuticals is looking to expand the portfolio
What Bayer Doubters Missed
Orion Q3 operating profit beats forecasts as Nubeqa royalties jump
China approves Bayer's asundexian in world-first for FXIa
China Approves Bayer's Asundexian: A Game-Changer in Stroke Prevention, ETPharma
Bayer banks on new market opportunities in China
Bayer's Asundexian Becomes First Factor XIa Inhibitor Approved In China For Stroke Prevention
Correction to Bayer Update | Morningstar
Bayer Gets China Approval for Stroke-Prevention Drug in Global First for New Class - Update | Morningstar
Bayer Gets in China Its First Global Approval for Stroke Prevention Drug | Morningstar
MNCs tap China for global scale
Bayer announces new data at ESMO 2026 on NUBEQA
Commerce minister Piyush Goyal discusses investment avenues with German companies
Midterms, rift with moms may be 'death knell' of MAHA-Trump alliance
Piyush Goyal discusses investment opportunities with Bayer, Fresenius
Ophthalmology Sector Emerges as Must-Win Battleground for Global Pharma: Eli Lilly, Merck & Co., AbbVie, Innovent Biologics, Hengrui Medicine and Leading Players Enter the Market
Piyush Goyal holds talks with Fresenius, Bayer, Knauf executives to explore deeper India collaboration
Bispecific dual T cell agonist invikafusp alfa in solid tumors: the phase 1/2 START-001 trial
RFK Jr. Adviser Calley Means Quits Amid Food Policy Delays
Bayer news
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
